Semi-targeted proteomics on two ovarian cancer serum samples, F10 and F12, from the sample set of the FOLFOX-4 study
Semi-targeted Mass Spectrometry proteomics study to detect 12 selected proteins of two serum samples belonging to the FOLFOX-4 study on heavly-pretreated ovarian cancer patients. The two samples, F10 and F12, are basal samples collected at before the first FOLFOX-4 treatment cycle (T0) and were selected for this study because they show a different proteome profile.
SEEK ID: https://fairdomhub.org/data_files/4088?version=4
Filename:
Semi-targeted proteomics FOLFOX-4_Ovarian cancer_V5.docx
Format: Word document
Size: 1.68 MB
Export PNG
Creators and SubmitterViews: 2148 Downloads: 69
Created: 11th Apr 2021 at 04:22
Last updated: 27th Jun 2021 at 18:13
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 4 (latest) Created 27th Jun 2021 at 18:13 by Maria Paola Costi
No revision comments
Version 3 Created 3rd May 2021 at 21:04 by Maria Paola Costi
No revision comments
Related items
Projects: NMTrypI - New Medicines for Trypanosomatidic Infections, Mass spectrometry proteomics for biomarker discovery, Thymidylate synthase dimer dissociation, BioTarget Database, Compound Data
Institutions: Università degli Studi di Modena e Reggio Emilia (UNIMORE)
https://orcid.org/0000-0002-0443-5402
Projects: Mass spectrometry proteomics for biomarker discovery, TEAD-(YAP) structure, function and inhibition, Thymidylate synthase dimer dissociation
Web page: Not specified
Programme: Cancer drug discovery preclinical research
Public web page: Not specified
